Niels Schaft

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Venues

International journal of molecular sciences

Cancers

The Journal of cell biology

Journal of immunology research

Universitätsklinikum Erlangen

Erasmus MC (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitätsklinikum Erlangen Oct 01 2002

Germany

Privat Dozent (PD) (assistant professor)/group leader/staff member/PI/Deputy head of RNA production for the GMP facility :: Dermatology

ErasmusMC Feb 01 1998 - Jan 31 2002

Netherlands

PhD-student :: Department of Medical Oncology

Education History

Erasmus MC

Netherlands

PHD :: Department of Medical Oncology

Universiteit van Amsterdam

Netherlands

MSC

Publications

Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie
Tumor Antigens beyond the Human Exome. International journal of molecular sciences 25 (9) (2024)
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie
Tumor Antigens beyond the Human Exome. International journal of molecular sciences 25 (9) (2024)
Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, Niels Schaft
Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells-Function and Therapeutic Potential. International journal of molecular sciences 25 (13) (2024)
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie
Tumor Antigens beyond the Human Exome. International journal of molecular sciences 25 (9) (2024)
Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, Niels Schaft
Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells-Function and Therapeutic Potential. International journal of molecular sciences 25 (13) (2024)
Dennis Christoph Harrer, Jan Dörrie, Niels Schaft
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. International journal of molecular sciences 24 (3) (2023)
Dennis Christoph Harrer, Jan Dörrie, Niels Schaft
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. International journal of molecular sciences 24 (3) (2023)
Dennis Christoph Harrer, Jan Dörrie, Niels Schaft
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. International journal of molecular sciences 24 (3) (2023)
Dennis Christoph Harrer, Charlotte Schenkel, Carola Berking, Wolfgang Herr, Hinrich Abken, Jan Dörrie, Niels Schaft
Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells. Cancers 14 (20) (2022)
Amke C Beenen, Tatjana Sauerer, Niels Schaft, Jan Dörrie
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases. International journal of molecular sciences 23 (15) (2022)
Laura Gehrcken, Tatjana Sauerer, Niels Schaft, Jan Dörrie
T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options. International journal of molecular sciences 22 (16) (2021)
Stefanie Hoyer, Valentina Eberlein, Gerold Schuler, Carola Berking, Lucie Heinzerling, Niels Schaft, Jan Dörrie
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation. International journal of molecular sciences 22 (21) (2021)
Naomi C Bosch, Lena-Marie Martin, Caroline J Voskens, Carola Berking, Barbara Seliger, Gerold Schuler, Niels Schaft, Jan Dörrie
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells. International journal of molecular sciences 22 (19) (2021)
Niels Schaft
The Landscape of CAR-T Cell Clinical Trials against Solid Tumors-A Comprehensive Overview. Cancers 12 (9) (2020)
Christopher Lischer, Martin Eberhardt, Tanushree Jaitly, Cornelia Schinzel, Niels Schaft, Jan Dörrie, Gerold Schuler, Julio Vera
Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma. Cancer research 79 (20) (2019)
Dennis C Harrer, Jan Dörrie, Niels Schaft
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges. International journal of molecular sciences 20 (23) (2019)
Manuel Wiesinger, Johannes März, Mirko Kummer, Gerold Schuler, Jan Dörrie, Beatrice Schuler-Thurner, Niels Schaft
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. Cancers 11 (8) (2019)
Dennis C Harrer, Gerold Schuler, Jan Dörrie, Niels Schaft
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia. International journal of molecular sciences 20 (11) (2019)
Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy. International journal of molecular sciences 19 (1) (2018)
Aykut Turan, Linda Grosche, Adalbert Krawczyk, Petra Mühl-Zürbes, Christina Drassner, Alexandra Düthorn, Mirko Kummer, Mike Hasenberg, Sylvia Voortmann, Holger Jastrow, Jan Dörrie, Niels Schaft, Max E Kraner, Katinka Döhner, Beate Sodeik, Alexander Steinkasserer, Christiane Silke Heilingloh
Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1. The Journal of cell biology 218 (2) (2018)
Dennis C Harrer, Bianca Simon, Shin-Ichiro Fujii, Kanako Shimizu, Ugur Uslu, Gerold Schuler, Kerstin F Gerer, Stefanie Hoyer, Jan Dörrie, Niels Schaft
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma. BMC cancer 17 (1) (2017)
Ilka Knippertz, Andrea Deinzer, Jan Dörrie, Niels Schaft, Dirk M Nettelbeck, Alexander Steinkasserer
Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation. Journal of immunology research 2016 (2016)

Niels Schaft.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Niels Schaft